Maximizing Upstream Efficiency to Accelerate Vaccine Development and Scalability
Explore advanced supplementation strategies to enhance cell culture performance, increase yields, reduce costs, and streamline scalable vaccine manufacturing processes.
Upstream cell culture plays a critical role in determining the success of vaccine development and manufacturing. Yet, achieving high yields, consistent performance, and cost efficiency remains a persistent challenge—especially as processes scale. Emerging supplementation strategies are helping scientists overcome these limitations by enhancing cell growth, improving productivity, and reducing reliance on costly or variable components. By integrating these approaches early in development, teams can unlock greater process robustness and accelerate timelines without major workflow changes.
Explore how optimizing your upstream strategy can drive more efficient, scalable vaccine production.
“Peptones” established supplements for vaccine applications”
Discover how peptones can transform your vaccine development process—enhancing cell growth, boosting viral yields, and reducing reliance on costly serum. Learn how these versatile supplements can improve efficiency, lower risk, and accelerate time to market. Download the article to unlock their full potential.
Download“Evaluation of animal origin-free peptones to enhance viral vector vaccine production”
Discover how animal origin–free peptones can elevate viral vector vaccine production—boosting cell growth, increasing titers, and reducing reliance on serum. See how optimized peptone blends deliver up to ~40% higher yields and improved process efficiency. Download the poster to explore the full data and insights.
Download“Animal origin-free Yeast and Soytone-based Fed Bactch Fermentation as a Versatile Platform for High-Yield Plasmid Production”
Unlock a scalable, animal origin–free approach to high-yield plasmid production. This poster reveals how yeast and soytone-based fed-batch fermentation boosts cell growth, minimizes byproducts, and achieves impressive yields across strains. Explore the data and discover how to optimize your upstream process.
Download“Reducing serum use and improving viral vector production with animal origin-free peptones”
See how animal origin–free peptones can reduce serum use while boosting viral vector yields and process consistency. Explore case studies showing improved cell growth, up to 50% higher titers, and cost-saving potential. Download the application note to uncover strategies for optimizing your vaccine manufacturing workflow.
Download“Rethinking peptones as first-line optimization tools”
Learn how early integration can boost cell density, extend viability, and unlock an increase of up to 100% or more in titer—without major process changes. Discover practical strategies to overcome performance plateaus and accelerate development timelines. Download the white paper to explore the full approach.
Download“Peptones tailored for vaccine production”
Designed specifically for human and animal health applications, we offer an extensive portfolio of animal origin-free and animal origin peptones to supplement a variety of media. Learn more about our peptone offerings that may help to enhance productivity and performance in your vaccine workflow.
Download